Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR

Clinical Research in Cardiology

Volumn 104, Issue 11, 2015, Pages 964-974

  Weber, Marcel ^a   Brüggemann, Eva ^a   Schueler, Robert ^a   Momcilovic, Diana ^a   Sinning, Jan Malte ^a   Ghanem, Alexander ^a   Werner, Nikos ^a   Grube, Eberhard ^a   Schiller, Wolfgang ^a   Mellert, Fritz ^a   Welz, Armin ^a   Nickenig, Georg ^a   Hammerstingl, Christoph ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Aortic stenosis; Left ventricular recovery; Pacemaker; TAVI; TAVR; Valvular heart disease; Ventricular conduction disturbances

Indexed keywords

AGED; AORTA VALVE STENOSIS; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICULAR CONDUCTION DEFECT; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PACING; HEART VENTRICULAR STIMULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PACEMAKER; PACEMAKER IMPLANTATION; QRS INTERVAL; SURVIVAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC PULMONARY ARTERY PRESSURE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; VERY ELDERLY; AORTIC VALVE STENOSIS; ATRIOVENTRICULAR BLOCK; CLINICAL TRIAL; COMORBIDITY; CONVALESCENCE; EPIDEMIOLOGY; GERMANY; HEART VENTRICLE; MORTALITY; MULTIMODALITY CANCER THERAPY; PREVALENCE; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ATRIOVENTRICULAR BLOCK; CARDIAC PACING, ARTIFICIAL; CAUSALITY; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; GERMANY; HEART VENTRICLES; HUMANS; MALE; PREVALENCE; RECOVERY OF FUNCTION; RISK FACTORS; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84945457094     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-015-0865-9     Document Type: Article

References (44)

1. Pai RG, Varadarajan P, Razzouk A (2008) Survival benefit of aortic valve replacement in patients with severe aortic stenosis with low ejection fraction and low gradient with normal ejection fraction. Ann Thorac Surg 86(6):1781–1789 S0003-4975(08)01670-6
2. El-Mawardy M, Wubken-Kleinfeld N, Schwarz B, Gordian K, Stocker B, Sier H, Toelg R, Geist V, Kraatz EG, Richardt G, Abdel-Wahab M (2014) Transcatheter aortic valve implantation in patients with severely reduced left ventricular systolic function: a single-center experience. Clin Res Cardiol 103(8):621–630. doi:10.1007/s00392-014-0691-5
3. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106(24):3006–3008
4. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198. doi:10.1056/NEJMoa1103510
5. Sedaghat A, Sinning JM, Vasa-Nicotera M, Ghanem A, Hammerstingl C, Grube E, Nickenig G, Werner N (2013) The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 102(11):821–829. doi:10.1007/s00392-013-0596-8
6. Beller CJ, Schmack B, Seppelt P, Arif R, Bekeredjian R, Krumsdorf U, Katus HA, Karck M, Kallenbach K (2013) The groin first approach for transcatheter aortic valve implantation: are we pushing the limits for transapical implantation? Clin Res Cardiol 102(2):111–117. doi:10.1007/s00392-012-0502-9
7. Puls M, Viel T, Danner BC, Jacobshagen C, Teucher N, Hanekop G, Schondube F, Hasenfuss G, Seipelt RG, Schillinger W (2012) The risk-to-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience. Clin Res Cardiol 101(7):553–563. doi:10.1007/s00392-012-0426-4
8. Haussig S, Schuler G, Linke A (2014) Worldwide TAVI registries: what have we learned? Clin Res Cardiol 103(8):603–612. doi:10.1007/s00392-014-0698-y
9. O’Sullivan CJ, Stortecky S, Buellesfeld L, Wenaweser P, Windecker S (2014) Preinterventional screening of the TAVI patient: how to choose the suitable patient and the best procedure. Clin Res Cardiol 103(4):259–274. doi:10.1007/s00392-014-0676-4
10. Bagur R, Rodes-Cabau J, Dumont E, Larochelliere RD, Doyle D, Bertrand OF, Cote M, Poirier P, Pibarot P (2011) Exercise capacity in patients with severe symptomatic aortic stenosis before and six months after transcatheter aortic valve implantation. Am J Cardiol 108(2):258–264. doi:10.1016/j.amjcard.2011.03.031
11. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123(3):299–308. doi:10.1161/CIRCULATIONAHA.110.946533
12. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, Thomas M, Kovac J, Spyt T, MacCarthy PA, Wendler O, Hildick-Smith D, Davies SW, Trivedi U, Blackman DJ, Levy RD, Brecker SJ, Baumbach A, Daniel T, Gray H, Mullen MJ (2011) Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 58(20):2130–2138. doi:10.1016/j.jacc.2011.08.050
13. Abdel-Wahab M, Zahn R, Horack M, Gerckens U, Schuler G, Sievert H, Naber C, Voehringer M, Schafer U, Senges J, Richardt G (2012) Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry. Clin Res Cardiol 101(12):973–981. doi:10.1007/s00392-012-0486-5
14. Khatri PJ, Webb JG, Rodes-Cabau J, Fremes SE, Ruel M, Lau K, Guo H, Wijeysundera HC, Ko DT (2013) Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med 158(1):35–46
15. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest A-M, Anderson RH, de Jaegere PPT, Serruys PW (2008) Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. J Am Coll Cardiol Intv 1(3):310–316. doi:10.1016/j.jcin.2008.04.007
16. Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence MS, Brown S, Khan SQ, Walker N, Trivedi U, Hutchinson N, De Belder AJ, Moat N, Blackman DJ, Levy RD, Manoharan G, Roberts D, Khogali SS, Crean P, Brecker SJ, Baumbach A, Mullen M, Laborde JC, Hildick-Smith D (2011) Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 123(9):951–960. doi:10.1161/CIRCULATIONAHA.109.927152
17. Martinez-Selles M, Bramlage P, Thoenes M, Schymik G (2015) Clinical significance of conduction disturbances after aortic valve intervention: current evidence. Clin Res Cardiol 104(1):1–12. doi:10.1007/s00392-014-0739-6
18. Chorianopoulos E, Krumsdorf U, Pleger ST, Katus HA, Bekeredjian R (2012) Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve((R)) aortic bioprosthesis. Clin Res Cardiol 101(5):349–355. doi:10.1007/s00392-011-0398-9
19. Akin I, Kische S, Schneider H, Liebold A, Ortak J, Bansch D, Rehders TC, Thiele O, Schneider R, Kundt G, Krenz H, Chatterjee T, Nienaber CA, Ince H (2012) Surface and intracardiac ECG for discriminating conduction disorders after CoreValve implantation. Clin Res Cardiol 101(5):357–364. doi:10.1007/s00392-011-0400-6
20. Hoffmann R, Herpertz R, Lotfipour S, Aktug O, Brehmer K, Lehmacher W, Autschbach R, Marx N, Lotfi S (2012) Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function. JACC Cardiovasc Interv 5(12):1257–1263. doi:10.1016/j.jcin.2012.08.011
21. Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P, Pilgrim T, Gloekler S, Khattab AA, Huber C, Carrel T, Eberle B, Meier B, Boekstegers P, Juni P, Gerckens U, Grube E, Windecker S (2012) Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol 60(6):493–501. doi:10.1016/j.jacc.2012.03.054
22. Lampe B, Hammerstingl C, Schwab JO, Mellert F, Stoffel-Wagner B, Grigull A, Fimmers R, Maisch B, Nickenig G, Lewalter T, Yang A (2012) Adverse effects of permanent atrial fibrillation on heart failure in patients with preserved left ventricular function and chronic right apical pacing for complete heart block. Clin Res Cardiol 101(10):829–836. doi:10.1007/s00392-012-0468-7
23. Eberhardt F, Hanke T, Fitschen J, Heringlake M, Bode F, Schunkert H, Wiegand UK (2012) AV interval optimization using pressure volume loops in dual chamber pacemaker patients with maintained systolic left ventricular function. Clin Res Cardiol 101(8):647–653. doi:10.1007/s00392-012-0439-z
24. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50(1):69–76 S0735-1097(07)01560-4
25. WMA (2008) The Declaration of Helsinki. The World Medical Association. http://www.wma.net/e/policy/b3.htm. Accessed 23 Jan 2009
26. Surawicz B, Childers R, Deal BJ, Gettes LS (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 53(11):976–981. doi:10.1016/j.jacc.2008.12.013
27. Douglas PS, Garcia MJ, DE Haines, Lai WW, Manning WJ, Patel AR, Picard MH, Polk DM, Ragosta M, Parker Ward R, Weiner RB (2011) ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 appropriate use criteria for echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr 24(3):229–267. doi:10.1016/j.echo.2010.12.008
28. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, Morehead A, Kitzman D, Oh J, Quinones M, Schiller NB, Stein JH, Weissman NJ (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17(10):1086–1119. doi:10.1016/j.echo.2004.07.013
29. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW (2011) Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 57(3):253–269. doi:10.1093/eurheartj/ehq406
30. Nazif TM, Williams MR, Hahn RT, Kapadia S, Babaliaros V, Rodes-Cabau J, Szeto WY, Jilaihawi H, Fearon WF, Dvir D, Dewey TM, Makkar RR, Xu K, Dizon JM, Smith CR, Leon MB, Kodali SK (2013) Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. doi:10.1093/eurheartj/eht376
31. Guetta V, Goldenberg G, Segev A, Dvir D, Kornowski R, Finckelstein A, Hay I, Goldenberg I, Glikson M (2011) Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am J Cardiol 108(11):1600–1605. doi:10.1016/j.amjcard.2011.07.020
32. Jilaihawi H, Chin D, Vasa-Nicotera M, Jeilan M, Spyt T, Ng GA, Bence J, Logtens E, Kovac J (2009) Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 157(5):860–866. doi:10.1016/j.ahj.2009.02.016
33. Houthuizen P, Van Garsse LA, Poels TT, de Jaegere P, van der Boon RM, Swinkels BM, Ten Berg JM, van der Kley F, Schalij MJ, Baan J Jr, Cocchieri R, Brueren GR, van Straten AH, den Heijer P, Bentala M, van Ommen V, Kluin J, Stella PR, Prins MH, Maessen JG, Prinzen FW (2012) Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation 126(6):720–728 doi:10.1161/CIRCULATIONAHA.112.101055
34. Jenkins C, Bricknell K, Chan J, Hanekom L, Marwick TH (2007) Comparison of two- and three-dimensional echocardiography with sequential magnetic resonance imaging for evaluating left ventricular volume and ejection fraction over time in patients with healed myocardial infarction. Am J Cardiol 99(3):300–306. doi:10.1016/j.amjcard.2006.08.026
35. Schueler R, Sinning JM, Momcilovic D, Weber M, Ghanem A, Werner N, Nickenig G, Grube E, Hammerstingl C (2012) Three-dimensional speckle-tracking analysis of left ventricular function after transcatheter aortic valve implantation. J Am Soc Echocardiogr 25(8):827–834. doi:10.1016/j.echo.2012.04.023
36. Sinning JM, Hammerstingl C, Vasa-Nicotera M, Adenauer V, Lema Cachiguango SJ, Scheer AC, Hausen S, Sedaghat A, Ghanem A, Muller C, Grube E, Nickenig G, Werner N (2012) Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol 59(13):1134–1141. doi:10.1016/j.jacc.2011.11.048
37. Sinning JM, Ghanem A, Steinhauser H, Adenauer V, Hammerstingl C, Nickenig G, Werner N (2010) Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 3(11):1141–1149. doi:10.1016/j.jcin.2010.09.009
38. Seiffert M, Sinning JM, Meyer A, Wilde S, Conradi L, Vasa-Nicotera M, Ghanem A, Kempfert J, Hammerstingl C, Ojeda FM, Kim WK, Koschyk DH, Schirmer J, Baldus S, Grube E, Mollmann H, Reichenspurner H, Nickenig G, Blankenberg S, Diemert P, Treede H, Walther T, Werner N, Schnabel RB (2014) Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol 103(8):631–640. doi:10.1007/s00392-014-0692-4
39. Sherif MA, Zahn R, Gerckens U, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Richardt G, Schneider S, Senges J, Brachmann J (2014) Effect of gender differences on 1-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multicenter real-world registry. Clin Res Cardiol 103(8):613–620. doi:10.1007/s00392-014-0690-6
40. Egenrieder S, Hill S, Backes M, Vohringer M, Sechtem U (2014) Contained aortic annulus rupture with persisting false aneurysm after transfemoral transcatheter aortic valve implantation. Clin Res Cardiol 103(8):599–601. doi:10.1007/s00392-014-0696-0
41. Diemert P, Lange P, Greif M, Seiffert M, Conradi L, Massberg S, Blankenberg S, Reichenspurner H, Hagl C, Schmitz C, Schrofel H, Treede H, Schymik G, Kupatt C (2014) Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol 103(3):183–190. doi:10.1007/s00392-013-0632-8
42. Chorianopoulos E, Krumsdorf U, Geis N, Pleger ST, Giannitsis E, Katus HA, Bekeredjian R (2014) Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis. Clin Res Cardiol 103(1):65–72. doi:10.1007/s00392-013-0624-8
43. Zuern CS, Eick C, Rizas KD, Stoleriu C, Barthel P, Scherer C, Muller KA, Gawaz M, Bauer A (2012) Severe autonomic failure in moderate to severe aortic stenosis: prevalence and association with hemodynamics and biomarkers. Clin Res Cardiol 101(7):565–572. doi:10.1007/s00392-012-0427-3
44. Thilo C, Maurer CJ, Berlis A, von Scheidt W, Kasel AM (2014) Successful management of cerebral embolism during TAVR. Clin Res Cardiol 103(4):329–331. doi:10.1007/s00392-013-0652-4